Numbers 4

Question 1

% fetal death and % fetal structural abnormalities in NT >6.5mm

Answer 1

20%

45%

Question 2

% fetal loss in 2nd trimester oligohydramnios

Answer 2

> 80%

Question 3

% pulmonary hypoplasia with SROM 21/40

Answer 3

90%

Question 4

% pulmonary hypoplasia with SROM 25/40

Answer 4

50%

Question 5

% pulmonary hypoplasia with SROM 29/40

Answer 5

10%

Question 6

Incidence of NTD

Answer 6

1-2:1000

Question 7

Recurrence of NTD after 1 pregnancy

Answer 7

5%

Question 8

Recurrence of NTD after 2 pregnancies

Answer 8

12%

Question 9

Recurrence of NTD after 3 pregnancies

Answer 9

20%

Question 10

Risk congenital heart disease in NT >3.5mm and normal chromosomes

Answer 10

6%

Question 11

% congenital heart disease picked up by 4 chamber view

Answer 11

40-50%

Question 12

% congenital heart disease picked up by 4 chamber view plus pulmonary and aortic outflow tracts

Answer 12

65-70%

Question 13

% CDH related to karyotype abnormalities

Answer 13

10-20%

Question 14

% exomphalos associated with fetal abnormalities

Answer 14

70-80%

Question 15

Incidence cleft lip or palate

Answer 15

1:1000

Question 16

Risk of cleft lip/palate recurrence with 1 child

Answer 16

4%

Question 17

% AC and EFW <5th centile with chromosomal defects

Answer 17

19%

Question 18

Abdo palpation and examination detects how many SGA

Answer 18

30%

Question 19

Risk severe sepsis with amniocentesis

Answer 19

<1:1000

Question 20

% women with breast cancer who become pregnant

Answer 20

<10%

Question 21

5yr survival rate breast cancer <50yo

Answer 21

80%

Question 22

% >15yo seropositive for VZV

Answer 22

> 90%

Question 23

% FVS if serological conversion <28/40

Answer 23

1%

Question 24

% FVS if serological conversion <28/40 without VZIG

Answer 24

2.8%

Question 25

% babes infected if VZV within 1-4/52 of delivery

Answer 25

50%

Question 26

% of infected VZV babes with clinical varicella

Answer 26

25%

Question 27

% obese AN women

Answer 27

21%

Question 28

% maternal arrests due to anaesthesia | and % of these obese

Answer 28

25% | 75%

Question 29

Increased risk of congenital abnormalities in GDM + obesity

Answer 29

3 fold

Question 30

Success rate of obese VBA

Answer 30

54.6%

Question 31

% breech at term deliveries

Answer 31

3-4%

Question 32

% babes that spontaneously turn to cephalic without ECV

Answer 32

8%

Question 33

% babes that spontaneously turn to cephalic with unsuccessful ECV

Answer 33

3-7%

Question 34

% babes reverting to breech after successful ECV

Answer 34

3%

Question 35

% EMCS within 24hrs from ECV

Answer 35

0.5% (90% due to PVB)

Question 36

% risk FMH in ECV

Answer 36

2.4%

Question 37

% abnormal US in RFM

Answer 37

11.6%

Question 38

% pregnancies uncomplicated with single RFM

Answer 38

70%

Question 39

CTG with accelerations reduces incidence of stillbirth by..

Answer 39

1.9 vs 26:1000

Question 40

USS reduces incidence of stillbirth by..

Answer 40

2 vs 3:1000

Question 41

Twin selective reduction - chance that co-twin survives

Answer 41

up to 82%

Question 42

Twin selective reduction - chance that co-twin dies

Answer 42

15-18%

Question 43

Twin selective reduction - risk PPROM

Answer 43

10-15%

Question 44

% twin pregnancies that are monochorionic

Answer 44

30%

Question 45

% monochorionic twins that are MCMA

Answer 45

1%

Question 46

% monochorionic twins with TTTS

Answer 46

15%

Question 47

% monochorionic twins with SGR

Answer 47

15%

Question 48

% monochorionic twins with TTTS with SGR

Answer 48

50%

Question 49

Risk of TAPS post laser ablation

Answer 49

13%

Question 50

% fetal loss with monochorionic vs dichorionic twins

Answer 50

14% vs 2.6%

Question 51

recurrence of TTTS post laser ablation

Answer 51

14%

Question 52

NICE - % congenital abnormalities in multiples

Answer 52

4.9%

Question 53

% spontaneous birth <35/40 in triplets

Answer 53

75%

Question 54

% spontaneous birth <37/40 twins

Answer 54

50-60%

Question 55

Urea level for renal replacement therapy in PET

Answer 55

17

Question 56

Risk recurrence future PIH with previous PIH

Answer 56

16-47%

Question 57

Risk recurrence future PET with previous PIH

Answer 57

2-7%

Question 58

Risk recurrence future PIH with previous PET

Answer 58

13-53%

Question 59

Risk recurrence future PET with previous PET

Answer 59

16%

Question 60

Risk recurrence future PET with previous PET Cx by severe PET/HELLP/eclampsia <34/40

Answer 60

25%

Question 61

Risk recurrence future PET with previous PET Cx by severe PET/HELLP/eclampsia <28/40

Answer 61

55%

Question 62

Survival of non-hydropic fetal anaemia from RC abs

Answer 62

94%

Question 63

Survival of hydropic fetal anaemia from RC abs

Answer 63

74% | overall 84%

Question 64

Anti D level of moderate risk

Answer 64

>4 <15

Question 65

Anti D level of severe risk

Answer 65

>15

Question 66

Anti c level of moderate risk

Answer 66

>7.5 <20

Question 67

Anti c level of severe risk

Answer 67

>20

Question 68

% severe SGA at 20/40 due to aneuploidy

Answer 68

20%

Question 69

% severe SGA at 20/40 due to infection

Answer 69

5%

Question 70

% SGA babes that are constitutionally small

Answer 70

50-70%

Question 71

Risk of CS if IOL for SGA (10th centile) with normal dopplers

Answer 71

6-9%

Question 72

Risk of CS if IOL for SGA with dopplers >95th centile

Answer 72

17-32%

Question 73

% depression in 1st year after birth

Answer 73

15-20%

Question 74

Postpartum pyschosis incidence

Answer 74

1-2:1000

Question 75

Vit D requirement in pregnancy

Answer 75

6000IU/day

Question 76

% polyhdramnios is idiopathic

Answer 76

60%

Question 77

% polyhydramnios caused by DM or and congestive heart failure

Answer 77

25%

Question 78

% polyhydramnios due to fetal anomalies

Answer 78

15%

Question 79

% worsening spasticity in SCI in pregnancy

Answer 79

10-15%

Question 80

VTE incidence in pregnancy

Answer 80

8:100,000

Question 81

Absolute risk VTE in pregnancy and puerperim

Answer 81

1-2:1000

Question 82

% of PET

Answer 82

3-5%

Question 83

% that combo of maternal risk factors, MAP, placental biomarkers (PLGF/PAPPA) and uterine artery doppler can predict early onset PET

Answer 83

88.5% Late onset 46.7% PIH 35.3%

Question 84

``` % Aspirin reduces: PET Fetal/NND FGR PTB ```

Answer 84

17% 14% 10% 8%

Question 85

Risk placenta accreta and hysterectomy if 1 CS

Answer 85

0.3-0.6%

Question 86

Risk placenta accreta and hysterectomy if 6 CS

Answer 86

6-9%

Question 87

Risk of accreta if current praevia

Answer 87

3%

Question 88

Risk of accreta if current praevia + 1 CS

Answer 88

11%

Question 89

Risk of accreta if current praevia + 2 CS

Answer 89

40%

Question 90

Risk of accreta if current praevia + 3 CS

Answer 90

60%

Question 91

Risk of accreta if current praevia + 4 CS

Answer 91

67%

Question 92

% shoulder dystocia in LGA

Answer 92

9-24%

Question 93

AFI >60th centile + EFW >71st centile - PPV for LGA?

Answer 93

85%

Question 94

Increasing maternal BMI >25% in pregnancy - sensitivity, specificity and NPV for LGA

Answer 94

86% 93% 97%

Question 95

Recurrence if previous shoulder dystocia

Answer 95

1-16%

Question 96

% pruritis in pregnancy and recurrence

Answer 96

18% | 80%

Question 97

Incidence of atopic eruption of pregnancy

Answer 97

1:300

Question 98

Incidence PEP

Answer 98

1:160-300

Question 99

Incidence pemphigoid

Answer 99

1:1700-50,000

Question 100

MCA PSV sensitivity for fetal anaemia

Answer 100

100%

Question 101

% VBAC's spontaneously labouring <39/40

Answer 101

10%

Question 102

Risk of transfusion with unsuccessful VBAC

Answer 102

3.2%

Question 103

% uterine rupture is asymptomatic

Answer 103

48%

Question 104

Risk uterine rupture with misoprostol

Answer 104

5%

Question 105

Steroids between 37-38+6/40 for CS reduces RDS from... to...

Answer 105

6.7% to 2.7%

Question 106

% autopsy provides classification of death in stillbirths

Answer 106

45.9%

Question 107

Stillbirth rate

Answer 107

1:200